A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia
NCT03538041
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Autoimmune Hemolytic Anemia
Interventions
DRUG:
Parsaclisib
Sponsor
Incyte Corporation